INTRODUCTION
============

Many microorganisms can cause foodborne diseases; however, *Shigella* has been identified as one of the most important agent of diarrhea by World Health Organization (WHO) ([@b44]). Kotloff et al. ([@b22]) reported that annual cases of shigellosis is around 165 million, with more than 1.1 million deaths. According to Silva et al. ([@b40]), shigellosis is currently an important health problem around the world, occurring predominantly in children younger than five years old, mainly in developing countries. Shigellosis is caused by *Shigella* spp., including *Shigella dysenteriae, Shigella flexneri, Shigella boydii* and *Shigella sonnei* ([@b23]). Among *Shigella* species, *S. flexneri* and *S. sonnei* are the most prevalent in the developing and industrialized countries, respectively ([@b33], [@b38]).

*Shigella* is generally transmitted by contaminated water, uncooked food, and by contact with infected individuals ([@b26], [@b44]). The low infective dose, as few as 200 viable organisms, facilitates the direct transmission (person to person spreading). Humans and few primates are the only known reservoirs of *Shigella* ([@b37], [@b44]), and transmission among humans are common. According to Navia and Gascón ([@b26]) foodborne outbreaks occur due to the clonal propagation of one or few *Shigella* strains.

*Shigella* invades the local epithelium of the colon (large intestine) in a stepwise format: entry into epithelial cells, intracellular multiplication, intra-and intercellular spreading, and killing of the host cell ([@b32]). Gastroenteritis caused by *Shigella* spp. is usually self-limited, although shigellosis is one of the few enteric infections in which antimicrobial agents are prescribed to reduce the duration of the illness and the period of *Shigella* excretion after symptoms subside. Consequently, increasing resistance against the most used antimicrobials has been observed ([@b18]).

In Brazil there are few reports on foodborne shigellosis, probably attributed to the fact that no current regulation requires the investigation of *Shigella* in water or foods. However, according to the Brazilian Health Minister Central Laboratory in Rio Grande do Sul (RS) State (FEPPS/LACEN/RS), this microorganism is frequently isolated from stools of patients with diarrhea in foodborne outbreaks in Southern Brazil.

*Shigella* has been characterized by diverse methods, including antibiotic resistance and genotyping methods in Brazil ([@b35]) and in other countries as Chile ([@b16]), Iran ([@b37]), and Spain ([@b15]). The determination of antibiotic resistance of *Shigella* has been carried out, since it can rapidly provide information about resistant strains ([@b3]) and also can serve as a preliminary typing method. However, due to the low discrimination power of the antimicrobial resistance typing, DNA based methods has been recommended. Among them, PCR-ribotyping has been applied with success because it is rapid to perform, presents relatively low cost and also has been used to type enteric pathogens such as *Salmonella* ([@b19], [@b27], [@b28]).

Based on this, the objective of the present study was to characterize *Shigella* isolates responsible for foodborne outbreaks occurred in the Southern Brazil for their antimicrobial resistance patterns and PCR-ribotypes.

MATERIAL AND METHODS
====================

Bacterial strains identification and serotyping
-----------------------------------------------

***Shigella* isolates**: *Shigella* isolates used in this study were obtained from stool samples of shigellosis patients and from foods involved in outbreaks occurred in different localities of Rio Grande do Sul State, Southern Brazil. *Shigella* isolates from foods were collected in a 12-month period, between August 2007 and August 2008. Samples of suspected foods were collected during epidemiological investigation of foodborne outbreaks carried out by the Sanitary Surveillance Division of Rio Grande do Sul. Based on symptoms and epidemiological data, the foodborne outbreaks were suspected to be salmonellosis or shigellosis. Samples were tested for compliance to the Brazilian Federal Regulation RDC 12/2001 ([@b2]) in the Central Laboratory of Rio Grande do Sul (FEPPS/IPB/LACEN/RS) following APHA methods ([@b1]). Before disposal, 1200 plates of XLD agar (Oxoid Ltd., Hampshire, England) and SS Agar (Oxoid Ltd., Hampshire, England) used for detection of *Salmonella,* were sent to the Food Microbiology Laboratory of the Food Science and Technology Institute of Federal University of Rio Grande do Sul (ICTA/UFRGS) for investigation of *Shigella* spp. Typical colonies of *Shigella* were selected (217), transferred to BHI Agar (Oxoid Ltd., Hampshire, England), and submitted to the following tests for identification: motility, hydrogen sulphide production, indole production, use of citrate, glucose, sucrose, and lactose fermentation in TSI agar (Oxoid Ltd., Hampshire, England), and lysine decarboxylase in LIA (Difco, Detroit, Michigan). After identification, *Shigella* isolates were confirmed by serological tests ([@b14]), using antisera supplied by Probac do Brasil (Sao Paulo, Brazil).

Other 149 *Shigella* isolates were obtained from fecal samples of patients presenting nausea, vomiting, and diarrhea, between January 2003 and December 2007 ([Table 1](#tbl1){ref-type="table"}). After identification of the strains by the Bacteriology Section of FEPPS/IPB/LACEN/RS, they were sent to the Food Microbiology Laboratory of ICTA/UFRGS for evaluation of the antimicrobial resistance and PCR-ribotyping.

Antimicrobial resistance testing
--------------------------------

*Shigella* isolates were analyzed for susceptibility to nine antimicrobial agents by the disc diffusion method according to the Clinical and Laboratory Standards Institute ([@b7]). The antimicrobials and their respective concentrations (µg/disc) were: ampicillin (AMP), 10; tetracycline (T), 30; gentamicin (GEN), 10; nalidixic acid (NAL), 30; chloramphenicol (C), 30; streptomycin (S), 10; ciprofloxacin (CIP), 5; supplied by Laborclin (Parana, Pinhais, Brazil) and sulfamethoxazole/trimethoprim (SXT), 25; kanamycin (K), 30. The disks were supplied by Oxoid (Hampshire, United Kingdom), and *Escherichia coli* ATCC 25922 used as a reference strain for internal control. For the purpose of typing, resistance patterns were determined, creating a numerical code based on the antibiotic resistance of each isolate. Resistance was classified as 1, intermediate resistance as 2, and full sensitivity as 3 ([@b42]).

PCR-Ribotyping
--------------

**Extraction of DNA**: the genomic DNA was extracted by heat treatment, as described below: one colony of each isolate was inoculated in 3 ml of BHI broth (Oxoid Ltd., Hampshire, England) and incubated overnight at 37º C. After incubation, 1 ml suspensions of bacterial cells were centrifuged at 5000xg for 4 minutes in a microcentrifuge Eppendorf model 5415C, at room temperature. The supernatant was discarded and the pellet was suspended in 1 ml of TE (10 mM Tris HCl, pH 8.0, 1 mM EDA pH 8.0). This step was repeated twice. The pellet was suspended in 100 µl of TE, kept in a thermal block for 10 minutes at 95° C, and then centrifuged at 14000xg for 20 seconds. The supernatant was used in the PCR reactions, as described below.

**PCR amplification**: the primers used in the test were proposed by Jensen and Hubner ([@b20]) and were specific for the amplification of the spacer region between 16S and 23S rRNA genes. The sequences of the primers were the following: 5' CAA GGC ATC CAC CGT GT 3' and 5' GTG AAG TCG TAA CAA GG 3'. Each set of PCR reactions included a control without DNA template. The PCR-Ribotyping mixture (25 µl) consisted of 2.5 µl of reaction buffer (100 mmol l^-1^ Tris HCl, 750 mmol l^-1^ KCl pH 8.8), 0.4 µl of 10 mmol l^-1^ dNTPs (5 mmol l^-1^ of each dATP, dCTP, dGTP, and dTTP), 1 µl of 50 mmol l^-1^ MgCl~2~, 2 µl of each primer (20 ρmol), 0.4 U of *Taq* DNA Polymerase 2 U/µl (Invitrogen, Sao Paulo, Brazil), 14.9 µl sterile ultrapure water, and 2 µl DNA. The program used for the amplification was as follows: one initial cycle of 94º C for 2 minutes, followed by 25 cycles of 94° C for 15s, 55º C for 4 minutes and 72° C for 1 minute, and a final extension step of 72º C for 30 minutes. Amplifications were carried out on a Minicycler (MJ Research, Watertown, MA, USA) and 10 µl of amplified products were resolved by electrophoresis in 2.0 % agarose gel in TBE buffer. The gels were stained with ethidium bromide, and visualized under UV light.

Strains with different electrophoretic DNA banding patterns were tested at least twice to evaluate the reproducibility of the method. *E*. *coli* ATCC 25922, *S. aureus* ATCC 25923, *E*. *coli* O157:H7, *S.* Cholerasuis ATCC 10708, and *S.* Enteritidis 3091/05 strains were used to evaluate the discriminatory power of the method. *S. Enteritidis* 3091/05 was used as a control strain in all PCR-Ribotyping amplifications. The amplified banding patterns were visually compared and ascribed to the same PCR-Ribotyping when their patterns were identical.

RESULTS AND DISCUSSION
======================

Isolation of *Shigella*
-----------------------

Three *Shigella* strains were isolated from food samples involved in foodborne outbreaks occurred in RS. Strains were identified as *S. flexneri* (n=2) and *S. sonnei* (n=1), and were isolated from plates considered negative for the presence of *Salmonella* by the Official Laboratory of RS (FEPPS/IPB/LACEN/RS). As the investigation of *Shigella* in foods is not mandatory in Brazil and no *Salmonella* was found in these food samples, the etiologic agent of those outbreaks could have been considered unidentified. According to Carmo et al. ([@b4]), the etiologic agent of 80% of the 3.737 notified foodborne outbreaks occurred in Brazil could not be identified. This high percentage of unidentified causal agents can be attributed to different factors as: lack of food samples to be analyzed, insufficient sensitivity of the analytical methods, emerging pathogens not investigated, and the lack of official mandatory regulation for certain food pathogens, including *Shigella*.

*Shigella* is phylogenetically related to *Salmonella,* and both are related to *Escherichia coli* ([@b17]). Based on this fact and on the lack of appropriate detection methods, the diagnosis of shigellosis is very difficult. Currently, there are no specific selective media for the isolation of *Shigella* from food samples. In the present work, the isolation of *Shigella* was possible using methods for *Salmonella* recommended by the American Public Health Association ([@b24]) and FDA ([@b14]). Recently Warren et al. ([@b43]) published a review about methods for detection of *Shigella* in foods, and cited such methodologies. The authors also emphasized the need for an appropriate conventional culture protocol specifically designed for the detection of *Shigella* in foods.

Human fecal samples
-------------------

The *Shigella* isolates obtained from human fecal samples (149) belonged to specie *S. flexneri* (71.1%), followed by *S. sonnei* (21.5%). Only one isolate (0.7%) was identified as *S. dysenteriae*. Ten isolates (6.7%) were identified only as *Shigella* spp. These results are similar to those obtained in Brazil by Peirano et al. ([@b35]), who studied 296 *Shigella* strains isolated from human fecal samples in the Laboratory for Cholera and Enteric Diseases (NRLCED) of Fundação Instituto Oswaldo Cruz, Rio de Janeiro, Brazil, during the period of 1999 to 2004. The majority of the strains (52.7 %) were *S. flexneri*, and 44.2 % were *S. sonnei*, 2.3 % were *S. boydii*, and only two (0.6%) were *S. dysenteriae*. Silva et al. ([@b40]) reported that *Shigella* was the fourth causative agent of diarrhea in 877 infants assisted by a public hospital in Rondonia, in the Western Amazon region, Brazil, and among 25 isolates identified to species level, 72% were *S. flexneri*, 12% *S. sonnei*, 12% *S. boydii,* and 4% *S. dysenteriae.*

Similar results were also reported in other countries. Savadkoohi and Kacho ([@b38]), in Iran, observed that among 260 *Shigella* strains isolated from stool samples *,* 70% were *S. flexneri* and 30% were *S. sonnei*. In counterpart, in the United States, according to the CDC, there is a prevalence of *S. sonnei.* Between 1999 and 2002, among 1,598 isolates obtained in the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), and identified to species level, 1,278 (80 %) were *S. sonnei*, 295 (18%) were *S. flexneri* (16%), 18 (1%) were *S. boydii*, and 7 (0.4%) were *S. dysenteriae* ([@b41]).

Besides varying according to the geographical area, being *S. sonnei* the prevalent specie (\>80 %) in developed countries and *S. flexneri* the most common specie in developing countries ([@b23]), the prevalence of *Shigella* species varies over time. According to the results of the present study, in 2003 only *S. flexneri* was isolated in RS. However, between 2004 and 2007, the occurrence of *S. sonnei* increased from 17.9% in 2004 to 43.5% in 2007. Consequently, the incidence of *S. flexneri* decreased expressively: in 2003 all isolates were identified as *S. flexneri,* but in 2007 they accounted for only 47.8% of the outbreaks ([Table 1](#tbl1){ref-type="table"}).

###### 

Etiologic agents of shigellosis occurred in Rio Grande do Sul, Brazil, during the period of 2003 to 2007.

  Year               Species       Number of cases   Percent (%)\*
  ------------------ ------------- ----------------- ---------------
  2003               *S. sonnei*   0                 0.00
  *S. flexneri*      6             100.00            
  2004               *S. sonnei*   10                17.86
  *S. flexneri*      46            82.14             
  2005               *S. sonnei*   8                 27.59
  *S. flexneri*      21            72.41             
  2006               *S. sonnei*   4                 11.43
  *S. flexneri*      22            62.86             
  *S. dysenteriae*   1             2.86              
  *Shigella* spp.    8             22.86             
  2007               *S. sonnei*   10                43.48
  *S. flexneri*      11            47.83             
  *Shigella* spp.    2             8.70              

According to Chuang, et al. ([@b8]), between 250 and 500 cases/year of shigellosis were identified in Taiwan from 1995 to 2000. The majority were caused by *S. flexneri* and *S. sonnei*, which accounted for 73.3% and 26.5% of the total strains isolated, respectively. However, from 2001 to 2003, *S. sonnei* replaced *S. flexneri* as the predominant specie in central Taiwan ([@b44]).

According to [Table 2](#tbl2){ref-type="table"}, *Shigella* was isolated most frequently from children under 5 years of age, accounting for 40.7% of the isolates. People aged 5--19 years were involved in approximately 19.0% of the cases, and those aged 20--59 years were identified in 16.1 % of the cases. The overall distribution of *Shigella* isolates by gender was similar, with females accounting for 44.3% of the isolates and male for 49.0%.

###### 

Distribution of cases of foodborne shigellosis occurred in Rio Grande do Sul between 2003 and 2007, according to age, gender and species of Shigella.

  Age Group          Species         Female   Male   Unknown   Total
  ------------------ --------------- -------- ------ --------- -------
  \< 1 Year          *S. flexneri*   7        5      0         12
  *S. sonnei*        0               1        0      1         
  *Shigella* spp.    0               1        0      1         
  1 to 4 Years       *S. flexneri*   16       17     0         33
  *S. sonnei*        2               5        0      7         
  *S. desynteriae*   0               1        0      1         
  *Shigella* spp.    1               4        0      5         
  5 to 9 Years       *S. flexneri*   6        6      0         12
  *S. sonnei*        4               4        0      8         
  *Shigella* spp.    0               1        0      1         
  10 to 19 Years     *S. flexneri*   3        4      0         7
  *S. sonnei*        1               0        0      1         
  20 to 29 Years     *S. flexneri*   3        3      0         6
  *S. sonnei*        2               1        0      3         
  *Shigella* spp.    1               0        0      1         
  30 to 39 Years     *S. flexneri*   3        3      0         6
  40 to 49 Years     *S. flexneri*   2        3      0         5
  50 to 59 Years     *S. flexneri*   0        1      0         1
  *S. sonnei*        1               0        0      1         
  *Shigella* spp.    1               0        0      1         
  60 to 69 Years     *S. flexneri*   1        1      0         2
  *S. sonnei*        1               0        0      1         
  70 to 79 Years     *S. sonnei*     1        0      0         1
  Unknown Age        *S. flexneri*   8        8      6         22
  *S. sonnei*        1               5        3      9         
  *Shigella* spp.    1               0        0      1         
  Total                                                        149

In United States, the *Shigella Surveillance: Annual Summary 2005* ([@b5]) reported that 30.0% of the cases of Shigellosis affected children under 5 years of age, 34.3% of them persons aged 5--19 years, and 26.6 % persons aged 20--59.

Differences on gender were not verified.

Antimicrobial resistance testing
--------------------------------

The antimicrobial resistance of 152 isolates of *Shigella* is shown in [Table 3](#tbl3){ref-type="table"}. The highest resistance percentages occurred against streptomycin (88.6%), ampicillin (84.6%), and sulfamethoxazole/trimethoprim (80.5%), and the highest frequency of intermediate resistance was displayed against kanamycin (61.7%). The majority of the isolates was sensitive to ciprofloxacin (96.6%), nalidixic acid (89.3%), and gentamicin (83.2%). Savadkoohi and Kacho ([@b38]) also reported high resistance rates to sulfamethaxazole/trimetoprim (73.8%) and to ampicillin (73.8%) in *Shigella* isolated from children with acute diarrhea in the North of Iran. The sensitivity to ciprofloxacin was similar to our results (97.3 %). Silva et al. ([@b40]) studied *Shigella* spp. isolated from a public hospital in Rondonia/Brazil, and demonstrated high levels of resistance to sulfamethoxazol/trimethoprim and ampicillin.

###### 

Antimicrobial resistance of *Shigella* spp. isolated from stools associated with foodborne outbreaks occurred in Rio Grande do Sul, Brazil, between 2003 and 2007

                            Antimicrobial resistance (%) of *Shigella spp.*                                                           
  ------------------------- ------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- -------
  AMP                       T                                                 GEN     NAL     CIP     C       S       SXT     K       
  Sensitive                 12.08                                             26.84   83.22   89.26   96.64   42.28   7.38    16.78   22.82
  Intermediate resistance   3.36                                              12.75   6.04    8.06    3.36    2.68    4.03    2.68    61.74
  Resistance                84.56                                             60.40   10.74   2.68    0.00    55.04   88.59   80.53   15.44

ampicillin (AMP); tetracycline (T); gentamicin (GEN); nalidixic acid (NAL); ciprofloxacin (CIP); chloramphenicol (C); streptomycin (S); sulfamethoxazole/trimethoprim (SXT); kanamycin (K).

In a study conducted in northeastern Brazil, Sidrim *et al.* ([@b39]) reported that 26 strains of *S. flexneri* were resistant to sulfamethoxazole/trimethoprim, ampicillin and tetracycline. Resistances to chloramphenicol and gentamicin were verified in 84.6% and 7.6% of the isolates, respectively, and all strains were sensitive to nalidixic acid and ciprofloxacin.

Both *S. flexneri* and *S. sonnei* showed high percentages of resistance to ampicillin, streptomycin, sulfamethoxazole/trimethoprim, but there were differences in resistance to other antimicrobial agents. More strains of *S. flexneri* were resistant to tetracycline (79.2 %) and chloramphenicol (73.6%) than *S. sonnei* (3.13 % and 6.25 %) (data not shown). In United States, the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), also reported that *S. flexneri* and *S. sonnei* presented differences in resistance against antimicrobial agents. In the NARMS Human Isolates Final Report, 2005, resistance to tetracycline and chloramphenicol was higher among *S. flexneri* while *S. sonnei* isolates showed a higher resistance to streptomycin and sulfamethoxazole/trimethoprim. The percentage of isolates with no detected resistance was low in *S*. *sonnei* (4.4%) and *S*. *flexneri* (5.8%) ([@b6]).

Based on the antimicrobial resistance of the isolates, they were grouped in 73 patterns ([Table 4](#tbl4){ref-type="table"}). Nine patterns grouped 44.1 % of the isolates.

###### 

Most expressive antimicrobial resistance patterns of Shigella isolated from fecal stool samples and from foods associated with foodborne shigellosis occurred in Rio Grande do Sul, Brazil.

  Pattern                              Phenotype                 Number of isolates for each pattern   \%      Numerical code
  ------------------------------------ ------------------------- ------------------------------------- ------- ----------------
  A                                    AMP, SXT, T, S, C (I:K)   36                                    23.68   111131233
  B                                    AMP, SXT, T, S (I:K)      9                                     5.92    111133233
  C                                    AMP, SXT, T, S, C, K      5                                     3.28    111131133
  D                                    AMP, SXT, T, S, C         5                                     3.28    111131333
  E                                    AMP, SXT, S (I:K)         5                                     3.28    113133233
  F                                    AMP, SXT, S               4                                     2.63    113133333
  G[\*](#tf4-1){ref-type="table-fn"}   GEN, (T:I), (C:I)         1                                     0.66    321332333
  H[\*](#tf4-1){ref-type="table-fn"}   (T:I), (C:I)              1                                     0.66    323332333
  I[\*](#tf4-1){ref-type="table-fn"}   (T:I), (SXT:I)            1                                     0.66    323333323

food samples. ampicillin (AMP); tetracycline (T); gentamicin (GEN); nalidixic acid (NAL); ciprofloxacin (CIP); chloramphenicol (C); streptomycin (S); sulfamethoxazole/trimethoprim (SXT); kanamycin (K).

The results indicated that 96.7% of the strains (147 isolates) were resistant to at least one drug and only two isolates were sensitive to all drugs tested. Multiple resistance, i.e. resistance to two or more drugs, was observed in 137 isolates (90.2 %) and, among them, 82.2% were resistant to three or more antibiotics. Food isolates were resistant only to gentamicin and presented intermediate resistance to chloramphenicol, tetracycline, and sulfamethoxazole/trimethoprim, belonging to the patterns G, H, and I ([Table 4](#tbl4){ref-type="table"}). The three food isolates belonged to three different and unique patterns, suggesting that they differ from the fecal stool isolates.

Resistance profile A contained 36 *S. flexneri* isolates, all resistant to ampicillin, sulfamethoxazole/trimethoprim, tetracycline, streptomycin, chloramphenicol, and intermediately resistant to kanamycin. Profile B grouped nine *S. flexneri* isolates (5.9%), differing from the profile A only by the sensitivity to chloramphenicol. Profile C and D grouped five *S. flexneri* isolates each, and profile E grouped five *S. sonnei* isolates. The remaining isolates (n=85) were grouped in further 65 patterns, and accounted for 55.9% of the tested isolates. The most multi-resistant were one *S. flexneri* isolate that presented resistance to ampicillin, sulfamethoxazole/trimethoprim, tetracycline, streptomycin, chloramphenicol, and kanamycin (profile M), and two *S. flexneri* isolates that presented resistance to ampicillin, sulfamethoxazole/trimethoprim, tetracycline, streptomycin, chloramphenicol, kanamycin, and gentamicin (profile N).

Several studies have reported the involvement of drug resistant *S. sonnei* and *S. flexneri* in foodborne diseases. For example, among 392 *Shigella* isolates obtained from stool specimens of persons with acute diarrhea in southern Trinidad, during 1997--2006, 75% of the *S. sonnei* isolates were resistant to all antibiotics tested (ampicillin, tetracycline, sulphamethoxazole/trimethoprim, amoxicillin-clavulanic acid, cefuroxime, chloramphenicol, ciprofloxacin, aztreonam, and gentamicin) ([@b30]). In Calcutta, during a 4-year period (2001 to 2004), all *S. flexneri* isolates obtained from hospitalized children with diarrhea between 2001 and 2004, were resistant to ampicillin, cotrimoxazole, tetracycline, nalidixic acid and fluoroquinolones ([@b33]).

Over a 12-year period, 68 *Shigella* isolates (31 *S. sonnei*, 30 *S. flexneri*, 4 *S. dysenteriae*, and 3 *S. boydii*) were collected in a French University Hospital from the stools of patients with recent history of travel to various parts of the world particularly Africa and tested for drug resistance. These isolates were often resistant to streptomycin, spectinomycin, trimethoprim, tetracycline, and sulfonamides, resistant to ampicillin and chloramphenicol (66 to 84 %), or resistant to nalidixic acid. Multi-resistance was verified in 87 % of the isolates, and a total of 13 antibiotic resistance patterns were identified ([@b13]).

In Brazil, a study conducted over a period of 24 months aiming to assess the resistance of enteropathogens isolated from children with diarrhea in Rondonia (Western Amazon region, Brazil) indicated high frequency of strains resistant to sulfamethoxazole/trimethoprim, ampicillin, amicacin, penicillin and cotrimoxazol. Eighteen *S. flexneri* isolates displayed resistance to multiple antibiotics, as well as a low frequency of resistance to nalidixic acid and quinolones (ciprofloxacin and norfloxacin) ([@b40]). Other study, comprising 62 *Shigella* (47 *S. flexneri*, and 15 *S. sonnei*) isolates selected from fecal samples and tested in Laboratory for Cholera and Enteric Diseases (NRLCED) of Fundação Instituto Oswaldo Cruz, Rio de Janeiro, Brazil, during 1999--2003, indicated that all isolates were susceptible to nalidixic acid, ciprofloxacin and gentamicin. All but one (cefalothin resistant) was cephalosporin-susceptible. A total of eight antimicrobial resistance profiles were identified. The profile AMP, SMX, TMP, SPT, STR, TET, CHL was the most common and grouped 38 *S. flexneri* isolates. Profile SMX, TMP, SPT, STR, TET contained 12 *S. sonnei* isolates ([@b34]).

Emerging patterns of antimicrobial resistance of *Salmonella* and *Shigella* species are a serious concern in several parts of the world where enteric and typhoid fever and other forms of salmonellosis and shigellosis are endemic. The emergence of multi-resistant strains has important clinical and public health implications for populations at risk, for this reason surveillance is continuously needed ([@b25]). The emergence of resistant *Shigella* spp. strains, resulting in increased mortality, presents a major threat to disease control, particularly in less developed countries where antibiotics are frequently prescribed on an empirical basis. According to Dromigny et al. ([@b12]) regular studies should be conducted in order to monitor drug resistance and contribute to bacterial diarrhea control efforts.

PCR-ribotyping
--------------

The PCR-ribotyping used in the study was able to discriminate *Shigella* species and other bacterial genera since samples containing DNA of *S. flexneri*, *S. sonnei*, *S. aureus* ATCC 25923, *S.* Cholerasuis ATCC 10708, and *S. Enteritidis* 3091/05 yielded distinct banding patterns. Interestingly, *Shigella* species presented the same banding as *E. coli* ATCC 25922 and *E. coli* O157:H7. According to Coimbra et al. ([@b9]) *Shigella* spp. (except *S. boydii* serotype 13) and *Escherichia coli* constitute a single DNA relatedness group, and on a strict scientific basis, the *Shigella* species should be considered as *E. coli* clones. Corroborating this similarity, *Shigella* spp. and enteroinvasive *E. coli* (EIEC) have been considered responsible for shigellosis in humans ([@b32]).

In this study, the 152 *Shigella* isolates (149 fecal stools isolates + 3 food isolates) subjected to PCR-Ribotyping analysis, presented three banding patterns, designated SH1, SH2, and SH3 ([Fig. 1](#fig1){ref-type="fig"}). Profile SH1 was composed by 116 *S. flexneri* isolates, and the banding pattern was constituted of two bands (480 and 570bp). Profile SH2 was composed by 35 *S. sonnei* isolates, presenting a banding pattern of three bands (350, 480, and 570bp). The profile SH3 contained the *S. dysinteriae* isolate, presenting a banding pattern of two bands (570, and 700bp), but their molecular weights were not the same as of SH1. A band of about 570bp was detected in all *Shigella* isolates.

![PCR-ribotyping profiles of *Shigella* isolated from foodborne shigellosis of Rio Grande do Sul State, Brazil.](bjm-41-966-g001){#fig1}

M = Ladder (1kp), 1 = *S. dysenteriae* (profile SH3), 2 = *S. flexneri* (profile SH1), 3= *S. sonnei* (profile SH2 *),* 4 = *Salmonella* Enteritidis 3091/05, 5 =Negative Control

In the present study, the PCR-ribotyping was able to differentiate *Shigella* species involved in foodborne shigellosis from *S.* Enteritidis 3091/05. This *Salmonella* strain presented the same genotypic pattern (by PFGE and DNA sequencing) as *S.* Enteritidis SE86, the main causative agent of investigated foodborne diseases in the State of RS, in the last years ([@b29]). Considering the difficulty to differentiate *Salmonella* from *Shigella* by conventional methods, the PCR-ribotyping method used in this study has proven to be suitable for the routine investigation of foodborne outbreaks in RS. Furthermore, the amplification of the intergenic spacer sequences using rRNA genes is well known as a good tool for typing bacteria ([@b10]). These spacer regions demonstrate extensive sequence and length variation that can be used to type bacteria at the genus, species and subspecies levels ([@b11], [@b20], [@b21]). PCR-ribotyping has some advantages when compared to other molecular methods, mainly because it is not time-consuming and inexpensive. For example, many reports have used PFGE for typing *Shigella* because it is very discriminatory and considered the "Gold Standard" for typing microorganisms ([@b15], [@b26], [@b36]), but this technique is cumbersome and expensive, hampering its implementation in public health laboratories.

The PCR-ribotyping banding patterns of ten isolates that could not be identified to species level, listed as *Shigella* spp, were similar to those presented by *S. sonnei* (n=2) and *S. flexneri* (n=8), suggesting that the ten isolates belonged to these two species. Serology experiments confirmed these results.

The results of this study indicate that the several *Shigella* strains involved in different Shigellosis outbreaks present the same PCR-ribotyping banding pattern and also the same resistance profile, suggesting that closely related strains may have been the causative agent of the outbreaks. According to Navia and Gascón ([@b26]), most often the cases or outbreaks of shigellosis occur due to the clonally propagation of one or a few strains.

It should be noted that PCR-rybotyping resulted in lower number of banding patterns that did the antibiotic resistance testing. Even though antimicrobial resistance in microorganisms could be mediated by plasmids or other transmissible DNA elements, not modifying chromosomal DNA, other molecular typing methods are required to assure the clonal relationship of the *Shigella* strains.

CONCLUSION
==========

Several *Shigella strains demonstrated similar PCR-rybotyping banding patterns and also antibiotic resistance profile, suggesting that closely related strains were responsible for the studied foodborne shigellosis outbreaks occurred in the State of Rio Grande do Sul. PCR-rybotyping was able to correctly differentiate species of Shigella,* demonstrating to be useful for foodborne outbreaks investigation.
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